Plain-English translation of NCT05464030 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Cancer research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is one of the first times this treatment has been tested in people.
This is an early-stage clinical trial testing a new medication called in people with advanced colorectal cancer. is designed to target and attack cancer cells by using an antibody combined with a cancer-killing drug. The trial will first figure out the safest dose, then test how well the treatment works, sometimes in combination with other established cancer medications.
Colorectal cancer that has spread or come back after standard treatment often has limited options. This medication represents a new approach that researchers hope may help patients whose cancer has stopped responding to existing therapies.
The trial has two phases: first, researchers test increasing doses of the medication to find the safest level, which takes about 4 months. Then, eligible participants may continue in an expansion phase for about 8 months, where some may receive the medication alone and others may receive it combined with other established cancer drugs. You would attend regular clinic visits for blood tests, imaging scans, and check-ins with your medical team to monitor how you are responding and manage any side effects.
AI-generated summary from trial data · Aug 12, 2026 · Not medical advice
United States